Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender

Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender

April 02, 2025 3:30 PM EDT | Source: Izotropic Corporation Vancouver, British Columbia and Sacramento,…

Continue Reading
Homeland Engages Kin Communications for Investor Relations Services and Independent Trading Group as Market-Maker

Homeland Engages Kin Communications for Investor Relations Services and Independent Trading Group as Market-Maker

Vancouver, British Columbia–(Newsfile Corp. – March 24, 2025) – Homeland Uranium Corp. (TSXV: HLU) (“Homeland” or…

Continue Reading
Petro-Victory Energy Corp. Engages Alliance Advisors IR for Investor Relations Services

Petro-Victory Energy Corp. Engages Alliance Advisors IR for Investor Relations Services

DALLAS, March 14, 2025 /CNW/ – Petro-Victory Energy Corp. (“Petro-Victory” or the “Company”) (TSX-V: VRY) is pleased…

Continue Reading
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences (Nasdaq: HSCS), an AI-powered medical technology company focused on transforming ECGs/EKGs for…

Continue Reading
Silver Crown Royalties Engages Investor Cubed for Investor Relations and Closes First Tranche of Non-Brokered Private Placement

Silver Crown Royalties Engages Investor Cubed for Investor Relations and Closes First Tranche of Non-Brokered Private Placement

TORONTO – February 24, 2025 (NEWMEDIAWIRE) – Silver Crown Royalties Inc. (“Silver Crown”, “SCRi”, the “Corporation”,…

Continue Reading
Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Quantum BioPharma TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)…

Continue Reading